|
|
Article: Romark Announces FDA Approval of Alinia(R) Tablets for Adults; Indications for Alinia(R) for Oral Suspension Also Extended.
- Article from:
- PR Newswire
- Article date:
- July 22, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
TAMPA, Fla., July 22 /PRNewswire/ -- Romark Laboratories announced today that the U.S. Food and Drug Administration (FDA) has approved Alinia(R) (nitazoxanide) Tablets for treating diarrhea caused by Giardia lamblia in patients 12 years of age and older. The Alinia Tablets received a priority review from the FDA.
The FDA also extended the approved uses of Alinia for Oral Suspension to include diarrhea caused by Giardia lamblia in patients 12 years of age and older. The suspension was approved by FDA late in 2002 for treating children 1 through 11 years of age with diarrhea caused by Giardia lamblia and Cryptosporidium parvum, another common cause of persistent ...